Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber’s Hereditary Optic Neuropathy

<div>GFP expression throughout the mouse retina three weeks after intravitreal injection of AAV2-CAG GFP. Image courtesy of Dr. Andrew Osborne and Dr. Tasneem Khatib.</div>

Neural Plasticity

fig1

Figure 1

Figure 1: Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber’s Hereditary Optic Neuropathy 